We are live on
!
Find out more
CSS
Cubist Systematic Strategies Portfolio holdings
AUM
$21B
1-Year Est. Return
21.48%
This Fund
S&P 500
This Quarter
Est. Return
+11.64%
1 Year Est. Return
+21.48%
3 Year Est. Return
+78.34%
5 Year Est. Return
+110.56%
10 Year Est. Return
+239.04%
AUM
$7.81B
AUM Growth
+$540M
(+7.4%)
Cap. Flow
-$59.7M
Cap. Flow
% of AUM
-0.76%
Top 10 Holdings %
Top 10 Hldgs %
4.74%
Holding
3,067
New
528
Increased
1,137
Reduced
1,133
Closed
263
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Aptiv
APTV
|
+$48.4M |
| 2 |
Apple
AAPL
|
+$40.9M |
| 3 |
PayPal
PYPL
|
+$33.6M |
| 4 |
Chubb
CB
|
+$30.7M |
| 5 |
Illumina
ILMN
|
+$28.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Danaher
DHR
|
+$36M |
| 2 |
Lockheed Martin
LMT
|
+$31.4M |
| 3 |
CDW
CDW
|
+$31.3M |
| 4 |
D.R. Horton
DHI
|
+$27.4M |
| 5 |
Fidelity National Information Services
FIS
|
+$27.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.29% |
| 2 | Consumer Discretionary | 15.76% |
| 3 | Healthcare | 14% |
| 4 | Financials | 13.56% |
| 5 | Industrials | 11.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AGRX
2576
DELISTED
Agile Therapeutics
AGRX
| $141K | ﹤0.01% |
+34
| New | +$184K |
|
|
EVFM
2577
DELISTED
Evofem Biosciences, Inc. Common Stock
EVFM
| $141K | ﹤0.01% |
+5,385
| New | +$245K |
|
|
AGEN
2578
Agenus
AGEN
$291M
| $139K | ﹤0.01% |
2,598
-3,451
| -57% | -$249K |
|
|
CPRX
2579
DELISTED
Catalyst Pharmaceutical
CPRX
| $139K | ﹤0.01% |
30,167
-1,166
| -4% | -$4.63K |
|
2580
Transmedics
TMDX
$3.07B
| $139K | ﹤0.01% |
3,347
+3,233
| +2,836% | +$99.5K |
|
2581
Gyre Therapeutics
GYRE
$749M
| $138K | ﹤0.01% |
+3,651
| New | +$167K |
|
|
RPTX
2582
DELISTED
Repare Therapeutics
RPTX
| $138K | ﹤0.01% |
4,505
+1,196
| +36% | +$40.6K |
|
2583
Senseonics Holdings Inc
SENS
$394M
| $138K | ﹤0.01% |
+2,620
| New | +$148K |
|
|
CAMP
2584
DELISTED
CalAmp Corp.
CAMP
| $138K | ﹤0.01% |
552
+39
| +8% | +$9.9K |
|
|
ROCC
2585
DELISTED
Ranger Oil Corporation Class A Common Stock
ROCC
| $138K | ﹤0.01% |
+10,268
| New | +$141K |
|
|
VXRT
2586
DELISTED
Vaxart
VXRT
| $137K | ﹤0.01% |
22,600
-8,068
| -26% | -$62.1K |
|
|
VBIV
2587
DELISTED
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
| $137K | ﹤0.01% |
+1,470
| New | +$149K |
|
|
NPTN
2588
DELISTED
NEOPHOTONICS CORP
NPTN
| $137K | ﹤0.01% |
+11,423
| New | +$130K |
|
|
NFH
2589
DELISTED
New Frontier Health Corporation Ordinary Shares
NFH
| $137K | ﹤0.01% |
+12,152
| New | +$124K |
|
|
SBBP
2590
DELISTED
Strongbridge Biopharma plc.
SBBP
| $134K | ﹤0.01% |
+48,481
| New | +$146K |
|
2591
TransAlta
TAC
$3.88B
| $133K | ﹤0.01% |
14,013
-80,278
| -85% | -$711K |
|
2592
Golar LNG
GLNG
$5.16B
| $132K | ﹤0.01% |
12,884
+11,425
| +783% | +$128K |
|
|
CANG
2593
Cango Inc
CANG
$67.7M
| $129K | ﹤0.01% |
+1,540
| New | +$157K |
|
2594
AXT Inc
AXTI
$4.83B
| $128K | ﹤0.01% |
10,981
-11,850
| -52% | -$142K |
|
2595
VEON
VEON
$3.87B
| $128K | ﹤0.01% |
+2,888
| New | +$127K |
|
|
TRIL
2596
DELISTED
Trillium Therapeutics Inc.
TRIL
| $128K | ﹤0.01% |
11,972
+4,172
| +53% | +$51.6K |
|
2597
Freshpet
FRPT
$3.26B
| $127K | ﹤0.01% |
801
-31,385
| -98% | -$4.73M |
|
|
EGIO
2598
DELISTED
Edgio, Inc. Common Stock
EGIO
| $127K | ﹤0.01% |
889
-5,713
| -87% | -$893K |
|
2599
B2Gold
BTG
$6.68B
| $126K | ﹤0.01% |
29,220
+8,045
| +38% | +$39.3K |
|
2600
Full House Resorts
FLL
$90.5M
| $126K | ﹤0.01% |
+14,821
| New | +$99.2K |
|
Similar funds
GIM
ECM
JFL
BAM
SF
WIM
AIM
SIG
Cubist Systematic Strategies's Q1 2021 Portfolio in Review
As of Q1 2021, Cubist Systematic Strategies held 3,067 positions worth $7.81B, up 7.4% from $7.27B the previous quarter. Its ten largest holdings account for 4.7% of the portfolio.
Cubist Systematic Strategies's Q1 2021 filing shows 528 new, 1,137 increased, 1,133 reduced and 263 closed positions. Its largest new stake was PhenomeX Inc. Common Stock: 210,710 shares worth $10.6M. The largest sale was Danaher, an estimated $36M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 19% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- Cubist Systematic Strategies's largest Q1 2021 buy was PhenomeX Inc. Common Stock: 210,710 shares worth $10.6M.
- Cubist Systematic Strategies added most to Aptiv in Q1 2021, an estimated $48.4M increase.
- Cubist Systematic Strategies's biggest Q1 2021 reduction was Danaher, cutting an estimated $36M.
- Cubist Systematic Strategies fully exited American Tower in Q1 2021, selling an estimated $19.5M.
- Cubist Systematic Strategies's ten largest holdings make up 4.7% of its $7.81B portfolio in Q1 2021.
- Cubist Systematic Strategies opened 528 new positions and closed 263 in Q1 2021.
- Cubist Systematic Strategies's portfolio value rose 7.4% quarter-over-quarter to $7.81B.
Based on Cubist Systematic Strategies's 13F filing for Q1 2021, filed 17 May 2021.